Abstract
Psoriasis is characterized by anomalous growth of keratinocytes (skin cells), which occurs due to abrupt signaling within immune cells and cytokines. The most significant immune cells, T cells go through differentiation with interaction of dendritic cells (DCs) to produce Type 1 T helper cell (\(\text {Th}_{1}\)) and Type 2 T helper cell (\(\text {Th}_{2}\)) subtypes. In psoriatic progression dynamics, the inflammation effect of \(\text {Th}_{1}\) mediated cytokines (pro-inflammatory) are responsible for the abnormal growth of keratinocytes. In this measure, the effect of anti-inflammatory cytokines secreted by \(\text {Th}_{2}\) subtype partially downregulate the growth of epidermal cell. In this research article, we have constructed a five-dimensional mathematical model involving T cells, dendritic cells, \(\text {Th}_{1}\), \(\text {Th}_{2}\), and keratinocyte cell populations for better understanding the development of psoriatic lesions. Moreover, we have evaluated the role of \(\text {Th}_{1}\), \(\text {Th}_{2}\), and interplay of various cytokine networks in Psoriasis through a set of nonlinear differential equations. Our analytical study reveals the preconditions for disease persistence and also validates the stability criteria of endemic equilibrium for the disease. Furthermore, we have used one-dimensional impulsive differential equation to examine the effects of different levels of biologic (\(\text{ Interleukin }\)-10) for different dosing intervals in keratinocytes cell population. We have also examined the qualitative behavior of keratinocyte by considering two different values of the parameter corresponding to the reduction of keratinocyte due to the impact of drug (IL-10). We have also found the perfect dosing intervals of biologic (\(\text{ Interleukin }\)-10) that could tolerate the keratinocytes at the desired level. Finally, our analytical and numerical computations reveal that the use of IL-10 through impulsive way is proven better treatment compared with other trivial therapeutic policies for psoriatic patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
World Health Organization, Global report on psoriasis 2016, WHO Library Cataloguing-in-Publication Data (2016)
T.J. Kindt, R.A. Goldsby, B.A. Osborne, J. Kuby, Kuby Immunology (Macmillan, London, 2007)
K. Liu, M.C. Nussenzweig, Origin and development of dendritic cells. Immunol. Rev. 234(1), 45–54 (2010)
A.K. Roy, P.K. Roy, E. Grigorieva, Mathematical insights on psoriasis regulation: role of Th 1 and Th 2 cells. Math. Biosci. Eng. 15(3), 717–738 (2018)
A. Coondoo, The role of cytokines in the pathomechanism of cutaneous disorders. Indian J. Derm. 57(2), 90 (2012)
A. Balato, F. Ayala, M. Schiattarella, M. Megna, N. Balato, S. Lembo, Pathogenesis of Psoriasis: The Role of Pro-inflammatory Cytokines Produced by Keratinocytes (INTECH Open Access Publisher, London, 2012)
J.H. Mao, E.F. Saunier, J.P. de Koning, M.M. McKinnon, M.N. Higgins, H.T. Yang, A. Balmain, R.J. Akhurst, Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. Proc. Natl. Acad. Sci. 103(21), 8125–8130 (2006)
A. Cavani, G. Girolomoni, Interferon-?-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. J. Investig. Derm. 110(2), 138–142 (1998)
A. Chiricozzi, E. Guttman-Yassky, M. Surez-Farinas, K.E. Nograles, S. Tian, I. Cardinale, S. Chimenti, J.G. Krueger, Integrative responses to IL-17 and TNF-a in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Investig. Derm. 131(3), 677–687 (2011)
A. Johnston, Y. Fritz, S.M. Dawes, D. Diaconu, P.M. Al-Attar, A.M. Guzman, C.S. Chen, W. Fu, J.E. Gudjonsson, T.S. McCormick, N.L. Ward, Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J. Immunol. 190(5), 2252–2262 (2013)
J. Baliwag, D.H. Barnes, A. Johnston, Cytokines in psoriasis. Cytokine 73(2), 342–350 (2015)
A.K. Roy, F. Al Basir, P.K. Roy, A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (\(\text{TNF}\)-\(\alpha \) inhibitor) therapy. J. Theor. Biol. 474, 63–77 (2019)
P. Goodwin, S. Hamilton, L. Fry, The cell cycle in psoriasis. Br. J. Derm. 90(5), 517–524 (1974)
G.D. Weinstein, J.L. McCullough, P.A. Ross, Cell kinetic basis for pathophysiology of psoriasis. J. Investig. Derm. 82(6), 623–628 (1984)
L.M. Johnson-Huang, M. Surez-Farias, K.C. Pierson, J. Fuentes-Duculan, I. Cueto, T. Lentini, M. Sullivan-Whalen, P. Gilleaudeau, J.G. Krueger, A.S. Haider, M.A. Lowes, A single intradermal injection of IFN-? induces an inflammatory state in both non-lesional psoriatic and healthy skin. J. Investig. Derm. 132(4), 1177–1187 (2012)
A. Mussi, C. Bonifati, M. Carducci, G. D’Agosto, F. Pimpinelli, D. D’Urso, L. D’Auria, M. Fazio, F. Ameglio, Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J. Biol. Regul. Homeost. Agents 11(3), 115–118 (1996)
A. Mussi, C. Bonifati, M. Carducci, G. D’Agosto, F. Pimpinelli, D. D’Urso, L. D’Auria, M. Fazio, F. Ameglio, Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J. Biol. Regul. Homeost. Agents 11(3), 115–118 (1997)
P. Nockowski, J.C. Szepietowski, M. Ziarkiewicz, E. Baran, Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris. Acta Derm.Venerologica Croat.: ADC 12(1), 2–6 (2003)
K.A. Papp, The long-term efficacy and safety of new biological therapies for psoriasis. Arch. Derm. Res. 298(1), 7–15 (2006)
K. Asadullah, W. Sterry, H.D. Volk, Interleukin-10 therapyreview of a new approach. Pharmacol. Rev. 55(2), 241–269 (2003)
K. Ghoreschi, P. Thomas, S. Breit, M. Dugas, R. Mailhammer, W. van Eden, R. van der Zee, T. Biedermann, J. Prinz, M. Mack, U. Mrowietz, Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 9(1), 40–46 (2003)
K. Reich, M. Bruck, A. Grafe, C. Vente, C. Neumann, C. Grabe, Treatment of psoriasis with interleukin-10. J. Investig. Derm. 111(6), 1235–1236 (1998)
M. Friedrich, W.D. Dcke, A. Klein, S. Philipp, H.D. Volk, W. Sterry, K. Asadullah, Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis. J. Investig. Derm. 118(4), 672–677 (2002)
I.B. McInnes, G.G. Illei, C.L. Danning, C.H. Yarboro, M. Crane, T. Kuroiwa, R. Schlimgen, E. Lee, B. Foster, D. Flemming, C. Prussin, IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J. Immunol. 167(7), 4075–4082 (2001)
A. Datta, D.K. Kesh, P.K. Roy, Effect of CD4\(+\) T-cells and CD8\(+\) T-cells on psoriasis: a mathematical study. IMHOTEP: Afr. J. Pure Appl. Math. 3(1), 1–11 (2016)
N.J. Savill, R. Weller, J.A. Sherratt, Mathematical modelling of nitric oxide regulation of rete peg formation in psoriasis. J. Theor. Biol. 214(1), 1–16 (2002)
P.K. Roy, A. Datta, Impact of perfect drug adherence on immunopathogenic mechanism for dynamical system of psoriasis. BIOMATH 2(1), 1212101 (2013)
E. Grigorieva, E. Khailov, P. Deignan, Optimal treatment strategies for control model of psoriasis, in 2017 Proceedings of the Conference on Control and its Applications, Society for Industrial and Applied Mathematics (2017), pp. 86–93
C.A.O. **anbing, A. Datta, F.A. Basir, P.K. Roy, Fractional-order model of the disease psoriasis: a control based mathematical approach. J. Syst. Sci. Complex. 29(6), 1565–1584 (2016)
P.K. Roy, A. Datta, S. Rana, The Fractional-order differential equation model of psoriatic pathogenesis: a mathematical study. Afr. Diaspora J. Math., New Series 15(2), 35–46 (2013)
P.K. Roy, A. Datta, Negative feedback control may regulate cytokines effect during growth of keratinocytes in the chronic plaque of psoriasis: a mathematical study. Int. J. Appl. Math. 25(2), 233–254 (2012)
A. Datta, P.K. Roy, T-cell proliferation on immunopathogenic mechanism of psoriasis: a control based theoretical approach. Control Cybern. 42 (2013)
E.J. Routh, A Treatise on the Stability of a Given State of Motion: Particularly Steady Motion (Macmillan and Company, London, 1877)
A. Hurwitz, On the conditions under which an equation has only roots with negative real parts. Sel. Pap. Math. Trends Control Theory 65, 273–284 (1964)
V. Lakshmikantham, D.D. Bainov, P.S. Simeonov, Theory of Impulsive Differential Equations (World Scientific, Singapore, 1989)
R.J. Smith, P. Cloutier, J. Harrison, A. Desforges, A mathematical model for the eradication of Guinea worm disease. In Understanding the Dynamics of Emerging and Re-Emerging Infectious Diseases Using Mathematical Models, 37/661(2), 133–156 (2012)
G. Magombedze, S. Eda, V.V. Ganusov, Competition for antigen between Th1 and Th2 responses determines the timing of the immune response switch during Mycobaterium avium subspecies paratuberulosis infection in ruminants. PLoS Comput. Biol. 10(1), e1003414 (2014)
Y. Kogan, Z. Agur, M. Elishmereni, A mathematical model for the immunotherapeutic control of the Th1/Th2 imbalance in melanoma. Discr. Cont. Dyn. Syst. Ser. B 18(4), 1017–1030 (2013)
Y. Kim, S. Lee, Y.S. Kim, S. Lawler, Y.S. Gho, Y.K. Kim, H.J. Hwang, Regulation of Th1/Th2 cells in asthma development: a mathematical model. Math. Biosci. Eng. 10(4), 1095–1133 (2013)
R. Fernandez-Botran, V.M. Sanders, T.R. Mosmann, E.S. Vitetta, Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J. Exp. Med. 168(2), 543–558 (1988)
P.K. Denman, D.S. McElwain, D.G. Harkin, Z. Upton, Mathematical modelling of aerosolised skin grafts incorporating keratinocyte clonal subtypes. Bull. Math. Biol. 69(1), 157–179 (2007)
G.D. Weinstein, J.L. McCullough, P.A. Ross, Cell kinetic basis for pathophysiology of psoriasis. J. Investig. Derm. 85(6), 579–583 (1985)
Acknowledgements
The research work is financially supported by DST-PURSE PROJECT (Phase-II), Government of India, Department of Mathematics, Jadavpur University, Kolkata-700032, India.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Roy, A.K., Roy, P.K. (2020). Treatment of Psoriasis by Interleukin-10 Through Impulsive Control Strategy: A Mathematical Study. In: Manchanda, P., Lozi, R., Siddiqi, A. (eds) Mathematical Modelling, Optimization, Analytic and Numerical Solutions. Industrial and Applied Mathematics. Springer, Singapore. https://doi.org/10.1007/978-981-15-0928-5_15
Download citation
DOI: https://doi.org/10.1007/978-981-15-0928-5_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0927-8
Online ISBN: 978-981-15-0928-5
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)